Loading...
Anti-TNFα Therapy for Inflammatory Bowel Diseases is Associated With Epstein-Barr Virus Lytic Activation
Anti-TNFα therapy, known to suppress T-cell immunity, is increasingly gaining popularity for treatment of autoimmune diseases including inflammatory bowel diseases (IBD). T-cell suppression increases the risk of B-cell EBV-lymphoproliferative diseases and lymphomas. Since EBV-lytic activation is ess...
Na minha lista:
| Udgivet i: | J Med Virol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868340/ https://ncbi.nlm.nih.gov/pubmed/26307954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.24331 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|